Vestcor Inc Increases Stake in Humana Inc. (NYSE:HUM)

Vestcor Inc boosted its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 146.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,914 shares of the insurance provider's stock after purchasing an additional 3,513 shares during the period. Vestcor Inc's holdings in Humana were worth $1,500,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the company. Farther Finance Advisors LLC raised its stake in Humana by 4.0% during the fourth quarter. Farther Finance Advisors LLC now owns 2,103 shares of the insurance provider's stock worth $533,000 after purchasing an additional 81 shares during the period. Wealthfront Advisers LLC raised its stake in shares of Humana by 130.7% in the 4th quarter. Wealthfront Advisers LLC now owns 31,408 shares of the insurance provider's stock valued at $7,969,000 after acquiring an additional 17,793 shares during the period. River Road Asset Management LLC purchased a new stake in shares of Humana in the 4th quarter valued at approximately $3,465,000. Pzena Investment Management LLC raised its stake in shares of Humana by 44.0% in the 4th quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock valued at $915,736,000 after acquiring an additional 1,103,132 shares during the period. Finally, Marathon Trading Investment Management LLC purchased a new stake in shares of Humana in the 4th quarter valued at approximately $1,162,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on HUM shares. Royal Bank of Canada reissued an "outperform" rating and issued a $283.00 price target on shares of Humana in a research note on Wednesday, February 12th. Cantor Fitzgerald reissued a "neutral" rating and issued a $290.00 price target on shares of Humana in a research note on Wednesday, February 12th. Truist Financial upped their target price on shares of Humana from $260.00 to $290.00 and gave the stock a "hold" rating in a research note on Monday, January 6th. JPMorgan Chase & Co. cut their target price on shares of Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a research note on Tuesday, February 18th. Finally, Piper Sandler upped their target price on shares of Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a research note on Wednesday, January 15th. Nineteen research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat, Humana has a consensus rating of "Hold" and a consensus target price of $285.68.

Remove Ads

Humana Stock Down 1.0 %

Shares of Humana stock traded down $2.77 during trading hours on Wednesday, hitting $267.01. The company had a trading volume of 1,508,672 shares, compared to its average volume of 1,714,713. The company's 50-day moving average is $271.45 and its two-hundred day moving average is $278.29. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $406.46. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The company has a market cap of $32.23 billion, a P/E ratio of 26.84, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57.

Humana (NYSE:HUM - Get Free Report) last issued its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.33%. The ex-dividend date of this dividend is Friday, March 28th. Humana's dividend payout ratio is currently 35.58%.

Insider Buying and Selling

In related news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. This represents a 31.16 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.37% of the stock is owned by company insiders.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.